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Abstract.  The ability of carcinomas to invade and to 
metastasize largely depends on the degree of epithelial 
differentiation within the tumors,  i.e., poorly differen- 
tiated being more invasive than well-differentiated 
carcinomas.  Here we confirmed this correlation by ex- 
amining  various human cell lines derived from blad- 
der, breast, lung,  and pancreas carcinomas.  We found 
that carcinoma cell lines with an epithelioid phenotype 
were noninvasive and expressed the epithelium-specific 
cell-cell adhesion molecule E-cadherin (also known as 
Arc-I, uvomorulin, and cell-CAM 120/80), as visual- 
ized by immunofluorescence microscopy and by 
Western and Northern blotting, whereas carcinoma 
cell lines with a fibroblastoid phenotype were invasive 
and had lost E-cadherin expression.  Invasiveness of 
these latter cells could be prevented by transfection 
with E-cadherin cDNA and was again induced by 
treatment of the transfected cells with anti-E-cadherin 
mAbs. These findings indicate that the selective loss 
of E-cadherin expression can generate dedifferentiation 
and invasiveness of human carcinoma cells, and they 
suggest further that E-cadherin  acts as an invasion 
suppressor. 
O 
Eg  90%  of the human tumors are carcinomas;  in 
these, transformed epithelial cells grow in an uncon- 
trolled fashion,  break through  the basement mem- 
brane, and invade the underlying mesenchyme.  Carcinomas 
can be subdivided by morphological and functional criteria: 
(a)  well-differentiated  carcinomas  largely  retain  epitheli- 
al tissue structures, they show well-developed intercellular 
junctions,  and they are generally weakly invasive,  and (b) 
poorly differentiated carcinomas are characterized by an amor- 
phous tissue structure,  they have fewer cell-to-cell junctions, 
and they are more invasive (Weinstein et al., 1976; Gabbert 
et al., 1985). It has also been shown that the state of differen- 
tiation and the degree of invasiveness of carcinomas can de- 
termine cancer prognosis. For instance, 80% of patients with 
well-differentiated  colorectal carcinomas  survive five and 
more years, in contrast to only 25 % of patients with diagno- 
sis of poorly differentiated  colorectal carcinomas (Morson 
and Dawson,  1979). 
These morphological and functional characteristics  of car- 
cinomas have been recognized years ago; the underlying mo- 
lecular basis, however, is only presently being investigated. 
Various oneogenes have been found to be implicated  in the 
genesis of human  carcinomas,  e.g.,  the ICt-ras oncogene 
(Boset ai.,  1987; Forrester et al.,  1987; Almoguera et al., 
1988),  and the HER-2/neu protooncogene (Slamon  et al., 
1987, 1989). Various tumor suppressor genes are mutated or 
deleted in human carcinomas, e.g., the retinoblastoma sus- 
ceptibility gene (Harbour et al.,  1988;  Lee et al.,  1988; 
Bookstein et al., 1990), the Wtlms tumor gene (Habor et al., 
1990; Gessler et ai., 1990), the p53 gene (Takahashi et al., 
1989; Nigro et al.,  1989; Tsai et ai.,  1990), the deleted in 
colon carcinomas (DCC) gene (Fearon et al., 1990), a gene 
on chromosome 5q (Bodmer et al.,  1987; Leppert et al., 
1987), and a gene (or genes) on chromosome 3p (Kok et al., 
1987; Zbar et al.,  1987; Kovacs et al.,  1988). 
Keratins and desmosomal proteins allow the identification 
and classification  of epithelial  tumors and can also be used 
for tracing back the origin of metastatic carcinomas (Osborn 
et al., 1977; Gabbiani et al., 1981; Osborn and Weber, 1983; 
Cooper et ai., 1985; Moll et al., 1986). Changes in the kera- 
tin expression  pattern which parallel  dedifferentiation  have 
recently been observed in bladder carcinomas (Moll et al., 
1988). The carcinoembryonic antigen (CEA) has been found 
to be a valuable indicator of carcinomas of the gastrointesti- 
nal tract (Mentges, 1987; Benchimol et ai., 1989; Daneker 
et al., 1989), the expression of urokinase and its receptor is 
restricted  to  dedifferentiated  colon  carcinoma  cell  lines 
(Boyd et al.,  1988), and the estrogen receptor represents  a 
useful marker  for differentiated  breast carcinomas  (Engel 
and Young, 1978; Sluyser,  1990). 
Our laboratory has  studied epithelial  differentiation  and 
invasion with respect to the expression and function of the 
epithelium-specific  cell-cell adhesion molecule E-cadherin, 
which various investigators  have  differently  named Arc-1 
(Imhof et  al.,  1983;  Behrens  et  al.,  1985),  uvomorulin 
(Hyafil et al., 1981; Vestweber and Kernler, 1984), L-CAM 
(Gallin et al.,  1983), E-cadherin  (Shirayoshi et al.,  1983), 
and  cell-CAM  120/80  (Damsky  et  al.,  1983).  We have 
demonstrated that  nontransformed  MDCK epithelial  cells 
1. Abbreviations used in this paper: C EA, carcinoembryonic antigen; DCC, 
deleted in colon carcinomas; DFKZ, German Cancer Research Center. 
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specifically inhibited by the addition of antibodies against 
E-cadherin; the separated ceils then assume a fibroblast-like, 
i.e., deditferentiated morphology, and invade collagen gels 
and  embryonal  heart  tissue.  Furthermore,  MDCK  cells 
transformed  with  Harvey  and  Moloney  sarcoma  viruses 
were found to be constitutively fibroblast-like and invasive, 
and they do not express E-cadherin. These data suggested 
that the loss of adhesive function of E-cadherin is a critical 
step in the promotion of epithelial cells to a dedifferentiated 
and invasive,  i.e.,  malignant stage (Behrens et al.,  1985, 
1989). 
The cell-adhesion molecule E-cadherin represents a 120- 
kD cell surface glycoprotein, of which extracellularly an 80- 
kD soluble tryptic fragment can be released in the presence 
of Ca  2+ (Hyafil et al.,  1981; Damsky et al., 1983; Gallin et 
ai., 1983;  Peyrieras et al., 1983).  In early mouse develop- 
ment E-cadherin functions as an adhesion component during 
compaction of blastomeres (Hyafil et al., 1981; Damsky et 
al.,  1983;  Shirayoshi et ai.,  1983;  Vestweber  and Kemler, 
1984),  at later stages it is confined to epithelia originating 
from ecto-, meso-, and endodermal tissue (Edelman et al., 
1983; Damsky et al.,  1983; Imhof et al.,  1983;  Vestweber 
and Kemler, 1984; Behrens et al., 1985).  In the epithelium 
of the small intestine, E-cadherin is enriched in the adherens 
junctions, in other epithelia it is present at the lateral cell sur- 
faces (Damsky et al., 1983; Boiler et al., 1985; Behrens et 
al.,  1985).  The full eDNA of the mouse molecule has re- 
cently been cloned; it codes for a signal peptide at the NH2 
terminus, a large extracellular domain with four repeats, a 
single transmembrane region, and a 15-kD cytoplasmic tail 
(Nagafuchi et al., 1987; Ringwald et al., 1987). After trans- 
fection of the eDNA  into fibroblasts,  functional Ca2+-de  - 
pendent contacts between the cells could be generated (Naga- 
fuchi et al., 1987; Mege et al., 1988;  Ozawa et all., 1989). 
E-cadherin belongs to a gene family; the closest relatives are 
N-cadherin (expressed in neural and muscle cells, Hatta et 
al.,  1985, 1988)  and  P-cadherin  (originally identified in 
mouse placenta but has also been found in a restricted set 
of human epithelia; Shimoyama et al., 1989a, b), a further 
relative is desmoglein (Koch et al., 1990). E-, N-, and P-cad- 
herin  exhibit a  unique  spatiotemporal  expression  pattern 
during emhryogenesis, and cells expressing different cadhe- 
rins sort out in vitro, suggesting that these adhesion mole- 
cules play a key role during morphogenesis (Takeichi,  1988; 
Nose et al.,  1988;  Miyatani et al.,  1989). 
In the present study we found that differentiated human 
carcinoma cell lines generally express E-eadherin and are 
noninvasive in vitro, whereas dedifferentiated cell lines do 
not express this cell-cell adhesion molecule and are invasive. 
Furthermore,  we  could  correct  the  invasive behavior  of 
dedifferentiated breast carcinoma cells by transfection with 
E-eadherin eDNA.  These results indicate that E-cadherin 
expression is crucial for the maintenance of  the differentiated 
noninvasive state of epithelial cells. 
Materials and Methods 
Cell Lines and Cell Culture 
The various differentiated and de.differentiated  human carcinoma cell lines 
were obtained from the tumor bank of  the German Cancer Research Center 
(DKFZ; Heidelberg, Germany) and the American Type Culture Collection 
(ATCC). The following cell lines were used: RT4 and RTII2 (DKFZ; from 
bladder carcinomas, differentiated);  EJ28 (DKFZ; from a bladder carcinoma, 
dedifferentiated); CX-1 (DKFZ),  WiDr, HCTII6,  SW948, and COLO205 
(ATCC; from colon carcinomas, differentiated); SW620 (ATCC; from a co- 
lon  carcinoma,  dedifferentiated);  MCF-7  (DKFZ),  and  MDA-MB-361 
• (ATCC; from breast carcinomas,  differentiated); BT-549 (ATCC; from a 
breast  carcinoma,  intermediate  phenotype);  MDA-MB-231, -435S, and 
-436  (DKFZ;  from breast  carcinomas,  dedifferentiated);  LX-I  (DKFZ; 
from a lung carcinoma, differentiated); A-427 and A-549 (DKFZ; from lung 
carcinomas,  intermediate phenotypes);  LXF289 and SK-MES-I (DKFZ; 
from lung carcinomas, dedifferentiated); Capan-l,  Capan-2,  and DAN-G 
(DKFZ; from pancreas carcinomas, differentiated); Hs 766T (DKFZ; from 
a pancreas carcinoma, intermediate phenotype); MIA PaCa-2 (ATCC; from 
a pancreas carcinoma, dedifferentiated). For more information on these cell 
lines see Table I. A-431 human vulva carcinoma ceils were obtained from 
ATCC, MRC-5 human lung fibroblasts were purchased from Flow Labora- 
tories Inc. (McLean, VA), and CSG 120/7 mouse salivary gland carcinoma 
cells were from L. M. Franks, London (Knowles and Franks, 1977). Cells 
were grown in DME and 10% FCS under standard cell culture conditions. 
The invasion assay on collagen gels was performed as described (Behrens 
et al.,  1989). 
Purification of the 80-kD Tryptic Fragment of Human 
E-cadherin and Production of  mAbs 
Our  rabbit  anti-canine  Arc-1 antiserum  (Behrens  et al.,  1989), which 
recognizes the human homologue was used for affinity purification of the 
80-kD tryptic fragment of E-cadherin from human A-431 carcinoma cells 
(for the expression of E-cadherin in A-431 cells see Damsky et al., 1983; 
Shimoyama  et al., 1989a). Tryptic digests of  the cells (Behrens et al., 1989) 
were chromatographed on an affinity column prepared by coupling 40 nag 
of the IgG fraction of the antiserum to 5 ml CNBr-Sepharose. The 80-kD 
fragment could then specifically be elnted with 5 mM EDTA, 500 mM 
NaCI, 50 mM Tris-C1, pH 8.5, and concentrated by acetone precipitation 
at -70°C. From 1 g of wet cells 1.5/tg of 80-kD tryptic fragment of  human 
E-cadherin could be isolated. 
For the production of  mAbs, BALB/c mice were immunized with the an- 
tigen (3 ~g per animal and immunization) using the ABM adjuvans system 
(Zymed Laboratories  Inc.,  South San Francisco, CA). Spleen ceils from 
immunized mice were fused with P3-X63-Ag 8.653 mouse myeloma cells 
(Keamey et al.,  1979). The resulting hybridomas were cultured in multi- 
well tissue culture plates. 
Screening of mAbs 
Hybridoma supernatants were screened in an enzyme-linked immunoassay 
using 96-well microtiter  plates  (Nunc,  Roskilde,  Denmark)  which were 
coated with 75 ng/well of the tryptic fragment of human E-cadherin. Anti- 
bodies bound to the solid-phase antigen were detected using peroxidase- 
coupled goat anti-mouse IgG antibodies (Jackson Immuno Research Labo- 
ratories, Avondale, PA). Positive hybridoma supernatants were rescreened 
by immunofluorescence on human A-431 carcinoma cells and on frozen sec- 
tions of  human small intestine following fixation with 3 % formaldehyde and 
treatment with 0.5%  Triton X-100, and by Western blot analysis of the 
80-kD fragment and of total A-431 cell extracts. For preparation of these 
extracts, freshly scraped A-431 cells were lysed for 5 min at 96°C with 2% 
SDS, 5 % 2-mercaptoethanol in L-CAM assay buffer (Cunningham et al., 
1984) followed by centrifugation at  100,000 g  at  12°C (Behrens et al., 
1989)~  Antibody  isotypes were  determined  using  a  mouse  monoclonal 
isotyping kit (Serotec, Oxford,  England). 
Analysis of E-cadherin in the Various  Human 
Carcinoma Cell Lines using Immunological Methods 
For the immunotluorescence of  E-cadherin in tissue culture cells, 100,000 g 
hybridoma supematants or Protein A-purified antibodies (eluted from Pro- 
rein  A-Sepharose with  50  mM  ethanoiamine,  pH  11)  were used.  Im- 
munofluorescence of cytokeratins was carded out according to Sun and 
Green (1978) using broad-spectrum antibodies (Jackson ImmunoResearch 
Laboratories and Camon Labor Service, Wiesbaden, Germany). For com- 
paring cell lines in Western blot experiments, 50 #g total cell protein (ex- 
tracted with SDS-buffer, see above) were loaded per gel lane. For quantita- 
tive antibody binding, human carcinoma cells were cultured overnight in 
96-well flexible microtiter plates (5 ×  104 cells/well), fixed with 3% form- 
aldehyde, and permeabilized with Triton X-100. After 1-h incubation with 
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lized MRC-5 human lung fibroblasts  for 1 h at room temperature) cells were 
washed and incubated with goat anti-mouse IgG (Jackson Immuno Re- 
search Laberatories Inc., Avondale,  PA) labeled with t25I using the lacto- 
peroxidase method (2 ×  107 cpm/#g; 5 x  105 cprn/well). Wells were then 
cut off and radioactivity of triplicate experiments was determined in a 
gamma counter. 
Northern Blot Analysis 
To obtain a human E-cadherin eDNA-probe, a human liver eDNA library 
(in the plasmid expression vector pUEX1; a gift of U. Loggen, Essen, Ger- 
many) was screened. Out of 1.6 x  105 clones, HC6-1 was picked and the 
insert was subcloned into MI3 phages and sequenced in beth directions by 
the dideoxy method using T7 DNA polymerase (Pharrnacia Fine Chemi- 
cals, Piscataway, NJ). 
For preparation of RNA, cells were washed with PBS, scraped off the 
plates with a rubber policeman, and lysed on ice in 1% NP40, 140 mM 
NaCI, 1.5 mM MgCI2, 100 U RNasin/ml, 10 mM Tris-C1, pH 8.0. After 
centrifugation  at 12,000 rpm in a rotor (model JA20;  Beckman Instruments, 
Inc., Palo Alto, CA), the supernatant was extracted at 65°C with acid phe- 
nol containing 1% SDS, 10 mM EDTA, followed  by extraction at room tem- 
perature with Tris-buffered phenol, phenol/chloroform, chloroform, and 
precipitation with ethanol at -20°C. Poly  A+-RNA  was obtained by aliin- 
ity chromatography of total RNA on oligo (dT)-cellulose using the spun 
column method (Pharmacia Fine Chemicals). RNA was electrophoresed  on 
glyoxal  gels (Maniatis  et ai., 1982) followed  by blotting on Hybend-N mem- 
branes (Amersharn Corp.,  Arlington Heights, IL).  Hybridization of the 
blots was carried out with nick-translated  eDNA-probes  overnight  at 64*C 
in 5× SSC, 5)< Denhardt's solution, 10% dextransulfate (Pharmacia Fine 
Chemicals), 0.5% SDS, 100 ttg/ml heated salmon sperm DNA. Filters were 
washed at room temperature with 2× SSC (2 ×  10 rain) and then with 0.5× 
SSC, 0.1% SDS at 64"C (two times 15 min) followed  by autoradiography 
with intensifying screens at -70°C. 
Transfection of  Mouse E-cadherin cDNA into 
Dedifferentiated Human Carcinoma Cells 
A subclone of dediffemntiated  human breast carcinoma cells (i.e., MDA- 
MB-435S/1) was  transfected using the  Ca2+-phosphate coprecipitation 
method with the full-length  eDNA of  mouse E-cadherin (plasmid  pBATEM 
2; E-cadherin under the control of the chicken ~-actin promoter; a gift of 
A. Nagafuchi and M. Takeichi, Kyoto, Japan) together with a plasmid for 
neomycin  resistance. G 418-resistant clones which exhibited an epithelioid 
morphology were analyzed  for  mouse E-cadherin expression by  im- 
mtmotfuorescence using supernatants of the DECMA-I rat hybridoma (a 
gift ofR. Kemler,  Freiburg, Germany). Invasion  of  the transfected  cells into 
collagen matrices was studied as described above. 
Results 
Characterization of Probes 
Mouse mAbs against the 80-kD tryptic fragment of human 
E-cadherin were generated and characterized. Antibody 6F9 
(an IgG1) reacted most specifically with the 120- and 80-kD 
E-cadherin bands on Western blots (Fig.  1, a  and b; c  and 
d  show the reaction with a  second antibody,  15C12,  and e 
andfis  the control reaction with the polyelonal rabbit anti- 
canine Arc-1 antibody, see also Behrens et al., 1989). In the 
immunofluorescence of frozen sections antibodies 6F9 and 
15C12 specifically stained the epithelium of the human small 
intestine; staining was confined to the lateral borders of the 
epithelial cells, and some enrichment was seen in the area 
of the junctional complex (data not shown, cf. also Behrens 
et al.,  1985). 
A  partial E-cadherin cDNA  clone,  HC6-1,  was isolated 
from a human liver plasmid eDNA library, and the insert was 
sequenced.  It encompasses 386 bp, which are homologous 
to  position  865-1251  of  the  full-size  mouse  E-cadherin 
eDNA (Nagafuchi et al., 1987), and the first 142 bp are iden- 
Figure 1. Western blot analysis of A-431 human carcinoma cell ex- 
tracts stained for E-cadherin with the new mAbs. Total cell extracts 
(lanes a, c, and e) and tryptic surface digests (lanes b, d, and f) 
of A-431 human vulva carcinoma cells were analyzed for the pres- 
ence of E-cadherin using the antibodies 6F9 (lanes a  and b) and 
15C12 (lanes c and d). As a control for the migration of the mature 
120-kD protein and the tryptic 80-kD fragment, the reaction with 
our polyclonal rabbit anti-canine Arc-1  antiserum is also shown 
(lanes e and f). This antiserum was used for the isolation of the hu- 
man 80-kD E-cadherin fragment which served as immunogen for 
the preparation and characterization of the new mAbs. (see Mate- 
rials and Methods). 
tical to the 3' end of  the published sequence of another partial 
human E-cadherin cDNA clone (Mansouri et al., 1988). The 
sequence of HC6-1 has the number X  52279  in the EMBL 
data bank. 
Expression of  E-cadherin in Differentiated 
and Dedifferentiated Human Carcinoma Cell Lines 
A variety of differentiated and dedifferentiated human carci- 
noma cell lines were obtained from the tumor cell bank of 
the German Cancer Research Center (DKFZ) and from the 
American Type Culture  Collection (ATCC).  We observed 
that cell lines isolated from well differentiated bladder, breast, 
lung, and pancreas carcinomas exhibited an epithelioid mor- 
phology in tissue culture, whereas most cell lines obtained 
from the respective poorly differentiated tumors expressed 
a  fibroblastoid shape (for more characteristics of these cell 
lines see Table I). A few cell lines expressed an intermediate 
phenotype. The state of differentiation in the tumors and in 
the resulting cell lines did not always correspond, e.g., in the 
case of colon carcinomas. We confirmed by immunofluores- 
cence of cytokeratins using a broad-spectrum antiserum that 
all cell lines were of epithelial origin (data not shown). 
By applying the new mAbs and the human eDNA probe 
we found that the differentiated (epithelioid) carcinoma cell 
lines expressed E-cadherin, whereas the dedifferentiated (fi- 
broblastoid) lines were usually negative. For instance, when 
tested by immunofluorescence with antibody 6F9, the differ- 
entiated bladder carcinoma cell line RT4 expressed E-cad- 
herin  in  the  areas  of cell-cell contact  (Fig.  2,  a  and  b), 
whereas  the  dedifferentiated bladder  carcinoma  cell  line 
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Morphology of 
Cell line  Characteristics related to differentiation  cultured cells* 
Bladder 
Colon 
Breast 
Lung 
Pancreas 
RT4  derived from a well-differentiated  carcinoma  (Rigby and Franks, 1970)  E 
RT112  derived from a well-differentiated  carcinoma (Steele et al.,  1983)  E 
EJ28  derived from an anaplastic carcinoma (Hastings and Franks, 1983)  F 
CX-I 
WiDr 
HCT116 
SW948 
COLO205 
SW620 
MCF-7 
MDA-MB-361 
BT-549 
MDA-MB-231 
MDA-MB-435S 
MDA-MB-436 
LX-1 
A-427 
A-549 
LXF289 
SK-MES-I 
Capan-1 
Capan-2 
DAN-G 
Hs 766T 
MIA PaCa-2 
well-differentiated  cell line (Daneker et al., 1989) 
derived from an adenocarcinoma,  differentiated  cell line (Noguchi  et al., 1979) 
epithelioid cell line in tissue culture (our finding;  compare with Boyd et al., 
1988) 
derived from an undifferentiated  adenocarcinoma,  differentiated  in culture 
(Leibowitz et al., 1976) 
derived from an anaplastic adenocarcinoma,  differentiated  in tissue culture 
(Semple et al., 1978) 
dedifferentiated  cell line (Leibowitz et al., 1976) 
characteristics  of  differentiated  mammary epithelium;  estrogen receptor-positive~ 
(Soule et al., 1973; Engel and Young,  1978) 
estrogen-receptor-positive  cell line (Engel and Young,  1978) 
derived from an invasive ductal tumor (ATCC) 
derived from a poorly differentiated  carcinoma, spindle-shaped  in culture; 
estrogen  receptor-negative  (CalIleau  et al.,  1974;  Engel and Young, 1978) 
spindle-shaped  cell  line  (Calllcau  et al.,  1978) 
spindle-shaped  cell  line  (Cailleau  et al.,  1978) 
derived from a human  tumor which was characterized as a moderately 
well-differentiated  adenocarcinoma  after passage in nude mice 
(H. L6hrke, Heidelberg, persona/communication) 
epithelial-like cell line, many cells with bizarre shapes (Giard et al., 1973) 
some characteristics of type II alveolar epithelial cells; vimentin-positive 
(Lieber et al., 1976; Blobel et al., 1984) 
derived from a moderately well-differentiated  adenocarcinoma; 
de.differentiated morphology in culture 
(H. L6hrke, Heidelberg, personal communication) 
cell line from a squamous carcinoma; vimentin-positive 
(Fogh and Trempe,  1975; Blobel et al., 1984) 
well-differentiated  adenocarcinoma  cells (Fogh et al., 1977) 
adenocarcinoma  cell line (Fogh et al., 1977) 
derived from a well-differentiated  carcinoma 
(H. L6hrke, Heidelberg, personal communication) 
derived from a lymph node metastasis (Owens et al., 1976) 
derived from an undifferentiated  carcinoma  (Yunis et al., 1977) 
E 
E 
E 
E 
E/Sph* 
Sph* 
E 
E 
F/Eli 
F 
E 
E/F[I 
F/EU 
F/Ell 
F 
*  Cells  were  grouped  according  to  their  morphology  in  cell  culture  as epithelloid  (E)  or fibroblastoid  (F). 
*  Sph,  cells  showed a spherical  morphology. 
§  The estrogen  receptor  is  a  widely  used  marker  for  differentiated  mammary carcinomas  (Engel  and Young, 1978). 
[I Cell lines with intermediate  morphology, whereby the first letter indicates  the dominant form. 
F_J28 did not show any fluorescence (Fig. 2, c and d). Simi- 
larly, the differentiated breast (MCF-7; Fig. 2, e and f), lung 
(LX-1; Fig. 3, a  and b) and pancreas (DAN-G; Fig. 3, e and 
f)  carcinoma cell lines expressed E-cadherin whereas the 
corresponding dedifferentiated breast (MDA-MB-435S; Fig. 
2, g  and h), lung (LXF289; Fig. 3,  c  and d), and pancreas 
(MIA PaCa-2;  Fig.  3,  g  and h) carcinoma cell lines were 
negative. 
The total amount of E-cadherin in these cell lines, as ob- 
served by Western blotting, largely corresponded with the 
immunofluorescence data. For instance, extracts of the dif- 
ferentiated  bladder  and  breast  carcinoma  cell  lines  were 
positive for the  120-kD polypeptide, whereas the dediffer- 
entiated bladder and breast carcinoma cell lines were nega- 
tive (Fig.  4). These differences were also seen with the second 
antibody 15C12 (data not shown). Northern blots revealed 
similar differences in  the E-cadherin mRNA  content. For ex- 
ample, the  differentiated  bladder, breast, lung, and pancreas 
carcinoma  cell lines expressed  E-cadherin-mRNA  well, 
whereas the corresponding  dedifferentiated carcinoma cell 
lines  did not show this  message (Fig. 5). Cell lines  with in- 
termediate phenotypes (e.g.,  A-427 and Hs 766T) expressed 
small amounts of mRNA. 
We also examined the human carcinoma cell  lines  (in  par- 
The Journal of Cell Biology,  Volume 113, 1991  176 Figure 2.  Immunofluorescence staining for E-cadherin in human bladder and breast carcinoma cell lines. The new mAb 6F9 was used 
in this experiment. (a and b) Differentiated bladder carcinoma cell line RT4; (c and d) dedifferentiated bladder carcinoma line EJ28; (e 
and f) differentiated breast carcinoma cell line MCF-7; and (g and h) dedifferentiated breast carcinoma line MDA-MB-435S. Apparently, 
the differentiated cell lines express E-cadherin at their:cell-cell  contact sites, whereas the dedifferentiated lines are negative. Bar, 20"~m~ 
Frixen et al.  Cell Adhesion  and Invasion  of Carcinoma  Cells  177  '~ Figure 3. Immunofluorescence staining for E-cadherin in human lung and pancreas carcinoma cell lines, mAb 6F9 was used. (a and b) 
Differentiated lung carcinoma cell line LX-1; (c and d) dedifferentiated lung carcinoma line LXF289; (e and f) differentiated pancreas 
carcinoma cell line DAN-G; and (8 and h) the dedifferentiated pancreas carcinoma cell line MIA PaCa-2. The differentiated lines express 
E-cadherin at the cell-cell contact sites, whereas the dedifferentiated lines are negative. Bar, 20/~m. 
The Journal of Cell Biology,  Volume i 13, 1991  178 Figure 4. Western blot of total carcinoma cell extracts stained for 
E-cadherin.  (lanes a and b) Extracts of the differentiated bladder 
carcinoma cell lines RTll2 and RT4; (lane c) of  the dedifferentiated 
bladder carcinoma line EJ28; (lane d) of the differentiated breast 
carcinoma  cell  line  MCF-7; and  (lanes  e  and  g)  of the  three 
dedifferentiated breast carcinoma lines MDA-MB-231, -435S, and 
-436 were analyzed using mAb 6F9; (lane h) is a control extract 
from differentiated human A-431 vulva carcinoma cells. Appar- 
ently, the differentiated cell lines express E-cadherin whereas the 
dedifferentiated lines are negative. 
ticular the ones which did not express E-cadherin) for the 
presence of intact E-cadherin genes by Southern blot analy- 
sis.  When cellular DNA was cleaved with five different re- 
striction enzymes (EcoRI, BamH, Hindm, AccI, SacI) and 
hybridized with the HC6-1 probe, no significant differences 
in the migration and intensities of the fragments could be de- 
tected (data not shown). Apparently, the E-cadherin gene in 
the dedifferentiated carcinoma cell lines is not deleted, and 
we could not find any gross rearrangement in the region cov- 
ered by our probe. We also tested whether the lack of expres- 
sion of E-cadherin in dedifferentiated cell lines might be be- 
cause of hypermethylation of the gene (of., Feinberg and 
Vogelstein,  1983;  Feinberg et al.,  1988).  In contrast, we 
found that the dedifferentiated cell lines rather exhibited a 
lower degree of methylation in the probed genomic region, 
as seen by new bands created by digestion with the enzyme 
Hpa!] (data not shown). 
Correlation between E-cadherin Expression 
and lnvasiveness In Vitro 
We then examined the various human carcinoma cell lines for 
invasiveness in the collagen assay (Behrens et al., 1989) and 
founda striking inverse correlation with the degree of  E-cad- 
herin expression. Thus, E-cadherin positive cell lines were 
largely noninvasive for collagen gels,  whereas the E-cad- 
herin-negative lines did penetrate into the gel (Fig. 6). Clear- 
cut examples are the bladder carcinoma cell lines RTll2, 
RT4, and EJ28; in the cases of  the breast, lung, and pancreas 
carcinoma cell lines,  a  gradual shift from the E-cadherin- 
expressing noninvasive state to the nonexpressing invasive 
state was observed. The differentiated colon carcinoma cell 
lines were all noninvasive; the fact that a  largely dediffer- 
entiated cell line (SW620) did not invade might be because 
of the predominantly spherical morphology of the cells (see 
also Table I). 
Prevention of the Invasiveness of 
Human Breast Carcinoma Cells by Transfection 
with E-cadherin cDNA 
Mouse E-cadherin cDNA was transfected into human breast 
carcinoma cells MDA-MB-435S/1 (see Materials and Meth- 
ods), and clones expressing various amounts of mouse E-cad- 
herin were observed. Of these, three stable epithelioid clones 
were finally established:  clone cad-B1 expressed mouse E-cad- 
herin well at the cell-cell contacts, as shown by staining with 
the mAb DECMA-1  (Fig.  7,  a  and b),  whereas a  control 
clone neo-lM did not (Fig. 7, c and d). Cad-Bl-cefis were still 
negative for human E-cadherin, as tested with antibody 6F9 
(Fig. 7 e; note that the two antibodies DECMA-1  and 6F9 
react in a species-specific manner with the mouse and human 
molecule, respectively; compare Fig.  7, b, e,  and f). 
The transfected breast carcinoma cells were then exam- 
ined for invasiveness in vitro.  The E-eadherin-expressing 
clone cad-B1 was found to be five times less invasive for col- 
lagen gels than the control clone neo-B4 (compare the black 
columns in Fig. 8, a and b) or the parental cell line (Fig. 6). 
However,  full  invasiveness  of the  cad-B1  cells  could  be 
regenerated by dissociating them with antibody DECMA-1 
(which specifically recognizes mouse E-cadherin, compare 
the checkered columns in Fig.  8, a  and b).  As  a  control, 
DECMA-1  also induced invasiveness of mouse carcinoma 
cells CSG 120/7 (Fig. 8 c). These data indicate that E-cad- 
herin  expression  converts  human  breast  carcinoma  cells 
MDA-MB-435S from a dedifferentiated invasive to a differ- 
entiated noninvasive state. They thus complement the exper- 
iments in which dedifferentiated invasive epithelial cells were 
generated by disturbance of E-eadherin-mediated cell-cell 
adhesion with specific antibody treatment (Fig. 8 c; see also 
Behrens et al.,  1989). 
Discussion 
In this  study we examined the expression of the cell-cell 
adhesion molecule E-cadherin (which has also been named 
Arc-l, uvomorulin, and cell-CAM-120/80) in a variety of  hu- 
man carcinoma cell lines originating from different tissues. 
Particular emphasis was directed toward changes of E-cad- 
herin expression which occur in the process of tumor de- 
differentiation. We found that cell fines derived from well 
differentiated human carcinomas (which keep the epithelial 
phenotype in tissue culture, 14 cell lines were tested) gener- 
ally express E-eadherin well, whereas the molecule is not 
detected in most cell lines from poorly differentiated carci- 
nonms (which exhibit a fibroblastoid phenotype in tissue cul- 
ture, nine cell lines were tested). As a correlate, E-cadherin- 
negative cell lines were found to be invasive for collagen 
gels, whereas E-cadherin-positive lines did generally not en- 
ter the extraceHular matrix. Furthermore, the invasiveness 
of dedifferentiated  breast carcinoma cells could be corrected 
by transfection with E-cadherin eDNA. These results show 
Frixen et al. Cell  Adhesion and Invasion of Carcinoma Cells  179 Figure 5. Northern blot analysis of various human carcinoma cell lines for the presence of E-cadherin mRNA. Electrophoresed poly A  +- 
RNA was blotted onto Hybond filters and hybridized with the HC6-1 eDNA probe (which recognizes E-cadberin mRNA) and with an 
actin eDNA probe (for the demonstration of  the loading in the three experiments). (A) Bladder (lanes a-c) and breast (lanes d-g) carcinoma 
cell lines: (lane a) RTII2; (lane b) RT4; (lane c) F_228; (lane d) MCF-7; (lane e) MDA-MB-231; (lane  f) MDA-MB-435S; and (lane g) 
MDA-MB-436. (B) Lung (lanes a-d) and pancreas (lanes e-g) carcinoma cell lines: (lane a) LX-1; (lane b) A-427; (lane c) SK-MES-1; 
(lane d) LXF289; (lane e) Capan-2 (lane f) DAN-G; and (lane g) Hs 766T. (lane h) Control mRNA from the bladder carcinoma cell 
line RTll2. (C) Colon carcinoma cell lines: (lane a) CX-1; (lane b) HCTll6; (lane c) SW620; (lane d) shows the absence of E-eadherin 
mRNA in MRC-5 human fibroblasts; (lane e) is control mRNA from the bladder carcinoma cell line RT112. Apparently, the differentiated 
carcinoma cell lines express E-cadherin mRNA, whereas the dedifferentiated lines are negative. The intermediate lines (A-427 and Hs 
766T) express a small amount of mRNA (cf. with Table I). 
that E-cadherin expression is a decisive indicator for differ- 
entiation and invasiveness of human carcinoma cells,  and 
they suggest that E-cadherin should now thoroughly be ex- 
amined for its possible role in preventing tumor cell invasion 
in vivo. 
Specificity of Probes 
We have here used new mAbs and a  cDNA-probe for ex- 
amining E-cadherin expression in the various human carci- 
noma cell lines. Since there exists a  family of Ca2+-depen  - 
dent cell-adhesion molecules, how can we be sure that our 
probes are specific for the epithelial form of the cadherins? 
First, we do not need to consider N-cadherin here, since this 
molecule exhibits a clearly different protease digestion pat- 
tern and a grossly different tissue distribution (Hatta et al., 
1985; Volk and Geiger, 1986; Takeichi, 1988). Second, the 
antigen used for immunization was prepared by affinity chro- 
matography on a polyclonal anti-E-cadherin antibody (i.e., 
our anti-Arc-I), and antibodies seem not to crossreact be- 
tween E- and P-cadherin (Behrens et al., 1985,  1989; Hatta 
et al.,  1985;  lhkeichi,  1988;  Shimoyama et al.,  1989a). 
Third, our mAbs stain the epithelium of the human small 
intestine and the cell contacts of MCF-7 human breast car- 
cinoma cells, which exclusively express E- but not P-cad- 
herin (Shimoyama et al.,  1989a). The sequence of the hu- 
man eDNA-probe was found to be most closely related to 
mouse E-cadherin and it is identical in its overlapping region 
to  a  partial  human  E-cadherin cDNA  (Nagafuchi  et  ai., 
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Figure 6. E-cadherin expression and invasiveness  in vitro of  the human carcinoma cell lines. For the invasion experiments, human carcinoma 
cell lines were cultured on collagen gels for 3 d and invasive cells were quantified in the light microscope (Behrens et al.,  1989). The 
expression of E-cadherin was measured separately in an indirect cell binding assay using mAb 6F9 and ~eSI-labeled  goat anti-mouse IgG. 
The values were corrected for unspecific binding of an unrelevant mAb. Note the lack of invasion in the E-cadherin-expressing carcinoma 
cell lines and the invasive activity of the negative lines. The dedifferentiated lung carcinoma cell line LXF289 was not included in this 
graph, since it did not attach well to the microtiter dishes and therefore, binding could not be quantified. LXF289 was clearly E-cadherin 
negative in the other assays and did invade the collagen gel (322 cells/cm2). The differentiated human vulva carcinoma cell line A-431 
was noninvasive. 
1987; Mansouri et al., 1988). Thus, both our antibodies and 
the cDNA-probe are specific and therefore suited for our 
purpose. 
E-cadherin Is a Valuable Marker of  Differentiated 
Noninvasive Human Carcinoma Cells 
Previously, human MCF-7 breast carcinoma, human A-431 
epidermoid carcinoma, and human JAR gestational chorio- 
carcinoma cells (which are all of  the differentiated  type) were 
found to express E-cadherin (Damsky et al., 1983). No de- 
differentiated carcinoma cell lines  were examined in this 
early report. Recently, E-cadherin expression was studied in 
low and high metastatic Variants of  the murine ovarian carci- 
noma cell line OV2944. In analogy to our present findings, 
a highly metastatic subline expressed only small amounts, as 
compared with the high level found in weakly metastatic 
lines (Hashimoto et al.,  1989). The cell lines we have used 
in the present study are of much greater variety of tissue ori- 
gin, and they were particularly selected to belong to either 
the differentiated or dedifferentiated type. For instance, the 
bladder carcinoma cell lines RTI12, RT4 (both differenti- 
ated), and EJ28 (dedifferentiated)  were previously character- 
ized for other epithelial markers; their cytokeratin expression 
pattern shows a good correlation with that of corresponding 
urothelial (transitional  cell)  carcinomas  of the  respective 
grade of malignancy (Moll et al., 1988). Furthermore, EJ28 
cells metastasized from the bladder of nude mice whereas 
RT4 cells did not (Ahlering et al., 1987). These bladder car- 
cinoma cell lines revealed a striking difference with respect 
to  E-cadherin expression and  corresponding invasiveness 
(Fig. 6). The breast carcinoma cell lines used were previ- 
ously characterized as either hormone dependent (e.g., the 
differentiated line  MCF-7,  which  expresses the  estrogen- 
receptor) or hormone  independent  (three dedifferentiated 
MDA-MB-Iines, which do not express the estrogen receptor; 
Engel and Young,  1978).  In addition, the MDA-MB-Iines 
231, 435S, and 436 synthesize vimentin and only low levels 
of keratins (Sommers et al., 1989), which is also consistent 
with their dedifferentiated state. Our study now shows that 
E-cadherin represents an additional differentiation marker of 
breast carcinoma cell lines which inversely correlates with 
invasiveness in vitro. In conclusion, E-cadherin thus func- 
tions as a differentiation marker for a variety of human carci- 
noma cells, i.e., from bladder, breast, lung, pancreas, and 
possibly other carcinomas, which is of more generality than 
other markers mentioned above. 
Frixen ct al. Cell Adhesion and Invasion of Carcinoma Cells  181 Figure  7. Immunofluorescence  staining of mouse E-cadherin  in transfected human breast carcinoma cells MDA-MB-435S/1. (a, b, and 
e) Human breast carcinoma clone cad-B1 transfected with mouse E-cadherin cDNA; (c and d) human control clone neo-B4; and (f) mouse 
CSG 120/7 carcinoma cells. The cells were stained with either mAh DECMA-1, which recognizes mouse E-cadherin  (b, d, and f), or 
with antibody 6F9, which marks human E-cadherin (e). Note that the transfected clone cad-B1 expresses mouse E-cadherin at the cell-cell 
contacts.  Bar, 20 #m. 
E-cadherin expression of various human carcinomas was 
studied by others on tissue sections,  and the molecule was 
found to be expressed in both differentiated and dedifferen- 
tiated  tumors  (Eidelman  et  al.,  1989;  Shimoyama et al., 
1989a).  However, much lower levels seem to be present in 
poorly differentiated carcinomas (see Fig. 7 Fin Shimoyama 
et al.,  1989a).  We have recently also examined the expres- 
sion of E-cadherin on sections of  various human carcinomas. 
We found a good correlation with the state of differentiation 
in the cases of ovarian carcinomas (Pfisterer et al.,  1990), 
of lobular breast carcinomas (Frixen, U. H., R. Moll, and 
W. Birehmeier, manuscript in preparation), and of squamous 
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Figure 8. Invasiveness  of human breast carcinoma ceils MDA-MB- 
435S/1 transfected with mouse E-cadherin. Cells were plated on 
collagen gels and invasion was scored over 3 d as described in 
Materials and Methods. (a) E-cadherin expressing human breast 
carcinoma done cad-B1; (b) negative  human clone sea-B4; and (c) 
mouse CSG 120/7 carcinoma cells. Black columns, invasion in the 
absence of antibody; checkered cohmms, invasion in the presence 
of the dissociating anti-mouse E-cadherin mAb DECMA-1. 
carcinomas of the head and neck (Schipper, J., U. H. Frixen, 
K. Jahnke, and W. Birchmeier, manuscript in preparation). 
An exception to the rule are ductal breast carcinomas; here 
invasive forms largely retain epithelial characteristics and 
express E-cadherin. 
E-cadherin Triggers the Conversion between the 
Invasive and Noninvasive States of Carcinoma Cells 
Considerable effort has been made in our laboratory and in 
the one of E  Van Roy and M. Marcel, Ghent, Belgium, to 
prove experimentally that E-cadherin expression is actually 
causal for inducing differentiation and preventing invasive- 
ness of epithelial cells. First, transfection with E-cadherin 
eDNA converted both dedifferentiated breast carcinoma and 
ms-transformed MDCK cells toward the noninvasive pheno- 
type (this report; Marcel et al., 1990).  Second, treatment of 
differentiated salivary gland carcinoma and MDCK epithe- 
lial cells with anti-E-cadherin antibodies induced invasive- 
ness (Fig. 8 c; Behrens et al., 1989).  These combined data 
suggest that E-cadherin represents a kind of master molecule 
for regulating the maintenance of epithelial differentiation. 
However, other factors can also come into play; for instance, 
scatter factor induces invasiveness of MDCK epithelial cells 
without affecting E-cadherin  expression  (Weidner et al., 
1990),  suggesting that this factor acts via another mech- 
anism. 
Control of E-cadherin Gene Expression 
We have observed that the relative amounts of E-cadherin 
protein and mRNA largely correspond to each other in the 
various carcinoma cell lines tested. When the E-cadherin 
gene was  examined by Southern blotting,  no deletion or 
gross rearrangement was yet detected in the nonexpressing 
cell lines. Thus, these results suggest that E-cadherin expres- 
sion is largely controlled on the transcriptional level. To fur- 
ther examine the molecular mechanisms that regulate E-cad- 
herin gene expression, the putative promoter of the E-cadherin 
gene has recently been isolated and characterized. A 270-bp 
genomic fragment (between -178 and -92) was found to be 
sufficient to induce a 20-fold higher CAT (chloramphenicol 
acetyltransferase)  expression  in  epithelial  cells  than  in 
fibroblasts, indicating that cis-regulatory elements control 
epithelial-specific E-cadherin expression (Behrens, J., and 
W. Birchmeier.  1990).  J.  Cell Biol. 111:157). 
In human hepatocellular carcinomas a loss of heterozygos- 
ity on chromosome 16 was recently detected in 52% of the 
informative cases, and the common region of allele loss was 
localized between the positions 16 q 22.1 and 23.2 (Tsuda et 
al., 1990). The human E-cadherin gene is located at position 
16 q 22.1 (Natt et al., 1989). Furthermore, loss of heterozy- 
gosity on chromosome 16 was much more frequent in poorly 
differentiated than in well-differentiated liver carcinomas. 
Thus, the E-cadherin gene is a good candidate for the tumor 
suppressor gene of chromosome 16 in hepatoceUular carci- 
nomas. Accordingly, the tumor suppressor gene "fat"  of Dro- 
sophila has recently been identified as a cadherin-like mole- 
cule (C. Goodman, personal communication). 
Comparison with Other Components Involved 
in Invasion and Metastasis of Human Carcinomas 
Recently, the nm 23/awd gene product was  identified by 
Steeg and collaborators, which is reduced in human mela- 
nomas, carcinomas, and sarcomas of high metastatic poten- 
tial, and which is homologous to the developmentally regu- 
lated gene abnormal wing discs of Drosophila (Rosengard et 
al.,  1989).  Reintroduction of this gene (which encodes for 
a cytoplasmic protein) into highly metastatic cells led to a 
correction  of the  metastatic phenotype.  The  DCC  gene, 
which is located on human chromosome 18 q, was found to 
be  affected in  70%  of colorectal  tumors  (Fearon  et al., 
1990). This gene codes for a putative cell-adhesion molecule 
of the N-CAM type, i.e., belongs to the immunoglobulin su- 
perfamily. The tumor marker CEA, which also belongs to 
the immunoglobulin superfamily, was found to function as 
a cell-cell adhesion molecule in colon adenocarcinoma cells 
(Benchimol et al., 1989). It is therefore likely that both cyto- 
plasmic  and cell  surface proteins  influence invasion and 
metastasis. The components discussed above (nm 23, DCC, 
16q 22.1 - 23.2, E-cadherin, fat) seem to promote the pro- 
Frixen  etal.  Cell Adhesion and Invasion  of Carcinoma Cells  183 cess  when  lost,  i.e.,  might  represent  true  invasion  and 
metastasis  suppressors. 
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